[1] SIEGELRL,MILLER KD,JEMAL A.Cancer statistics,2020［J］.CA Cancer J Clin,2020,70(1):7-30.
[2] SALANIR,BACKES FJ,FUNGMF,et al.Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies:Society of Gynecologic Oncologists recommendations［J］.Am J Obstet Gynecol,2011,204(6):466-478.
[3] HONG JY,OH IH,MCCREA PD.Phosphorylation and isoform use in p120-catenin during development and tumorigenesis［J］.Biochim Biophys Acta,2016,1863(1):102-114.
[4] GREEN KJ,ROTH-CARTER Q,NIESSEN CM,et al.Tracing the evolutionary origin of desmosomes［J］.Curr Biol,2020,30(10):R535-R543.
[5] HATZFELD M,WOLF A,KEIL R.Plakophilins in desmosomal adhesion and signaling［J］.Cell Commun Adhes,2014,21(1):25-42.
[6] NIELL N,LARRIBA MJ,FERRER-MAYORGA G,et al.The human PKP2/plakophilin-2 gene is induced by Wnt/β-catenin in normal and colon cancer-associated fibroblasts［J］.Int J Cancer,2018,142(4):792-804.
[7] TAKAHASHI H,NAKATSUJI H,TAKAHASHI M,et al.Up-regulation of plakophilin-2 and down-regulation of plakophilin-3 are correlated with invasiveness in bladder cancer［J］.Urology,2012,79(1):240.e1-8.
[8] WU Y,LIU L,SHEN XY,et al.Plakophilin-2 promotes lung adenocarcinoma development via enhancing focal adhesion and epithelial-mesenchymal transition［J］.Cancer Manag Res,2021,13:559-570.
[9] ZHANG DG,QIAN YX,LIU XX,et al.Up-regulation of plakophilin-2 is correlated with the progression of glioma［J］.Neuropathology,2017,37(3):207-216.
[10] XIE HY,XU H,HOU Y,et al.Integrative prognostic subtype discovery in high-grade serous ovarian cancer［J］.J Cell Biochem,2019,120(11):18659-18666.
[11] JIANG YT,WANG CD,ZHOU ST.Targeting tumor microenvironment in ovarian cancer:Premise and promise［J］.Biochim Biophys Acta Rev Cancer,2020,1873(2):188361.
[12] BROUSSARD JA,GETSIOS S,GREEN KJ.Desmosome regulation and signaling in disease［J］.Cell Tissue Res,2015,360(3):501-512.
[13]HOFMANN I.Plakophilins and their roles in diseased states［J］.Cell Tissue Res,2020,379(1):5-12.
[14] CHEN XY,BONNE S,HATZFELD M,et al.Protein binding and functional characterization of plakophilin 2.Evidence for its diverse roles in desmosomes and beta-catenin signaling［J］.J Biol Chem,2002,277(12):10512-10522.
[15] FRANKE WW.Discovering the molecular components of intercellular junctions-a historical view［J］.Cold Spring Harb Perspect Biol,2009,1(3):a003061.
[16] FRANKE WW,RICKELT S,BARTH M,et al.The junctions that don't fit the scheme:special symmetrical cell-cell junctions of their own kind［J］.Cell Tissue Res,2009,338(1):1-17.
[17] GROSSMANN KS,GRUND C,HUELSKEN J,et al.Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation［J］.J Cell Biol,2004,167(1):149-160.
[18] PAPAGERAKIS S,SHABANA AH,DEPONDT J,et al.Immunohistochemical localization of plakophilins (PKP1,PKP2,PKP3,and p0071) in primary oropharyngeal tumors:correlation with clinical parameters［J］.Hum Pathol,2003,34(6):565-572.
[19] DEMIRAG GG,SULLU Y,GURGENYATAGI D,et al.Expression of plakophilins (PKP1,PKP2,and PKP3) in gastric cancers［J］.Diagn Pathol,2011,6:1.
[20] ARIMOTO K,BURKART C,YAN M,et al.Plakophilin-2 promotes tumor development by enhancing ligand-dependent and -independent epidermal growth factor receptor dimerization and activation［J］.Mol Cell Biol,2014,34(20):3843-3854.
[21] HAO XL,TIAN Z,HAN F,et al.Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma［J］.Pathol Res Pract,2019,215(7):152438.
[22] SIGISMUND S,AVANZATO D,LANZETTI L.Emerging functions of the EGFR in cancer［J］.Mol Oncol,2018,12(1):3-20.
[23] LONDON M,GALLO E.Epidermal growth factor receptor (EGFR) involvement in epithelial-derived cancers and its current antibody-based immunotherapies［J］.Cell Biol Int,2020,44(6):1267-1282.